Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Friday. The firm set a “hold” rating on the stock.

Milestone Scientific Stock Performance

Shares of MLSS stock opened at $0.97 on Friday. The stock’s 50 day simple moving average is $0.88 and its 200 day simple moving average is $0.75. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.10. The company has a market capitalization of $74.53 million, a price-to-earnings ratio of -9.65 and a beta of 0.88.

Milestone Scientific (NYSE:MLSS) last issued its quarterly earnings results on Thursday, August 15th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The business had revenue of $1.85 million during the quarter. Milestone Scientific had a negative return on equity of 93.64% and a negative net margin of 74.50%.

Insiders Place Their Bets

In other Milestone Scientific news, Director Leonard Osser sold 141,913 shares of Milestone Scientific stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $0.95, for a total value of $134,817.35. Following the transaction, the director now directly owns 4,602,506 shares of the company’s stock, valued at approximately $4,372,380.70. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 24.75% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.